These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7247675)

  • 41. Occult hepatitis B virus infection.
    Allain JP
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of hepatitis B surface antigen in potentially contaminated human plasma and plasma fractions.
    Harris RB; Semar M; Johnson AJ
    J Lab Clin Med; 1977 Dec; 90(6):1107-14. PubMed ID: 336817
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of hepatitis B and C and blood donors.
    Mehdi SR; Pophali A; Al-Abdul Rahim KA
    Saudi Med J; 2000 Oct; 21(10):942-4. PubMed ID: 11369958
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical and virological evaluation of the detection of pre-S1 and pre-S2 antigens in serum from patients with chronic hepatitis B].
    Zoulim F; Capel F; Berthillon P; Trépo C; Petit MA
    Gastroenterol Clin Biol; 1995 Dec; 19(12):970-5. PubMed ID: 8729407
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
    Singh B; Verma M; Verma K
    Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
    Katz L; Strong DM; Tegtmeier G; Stramer S
    Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The epidemiology of hepatitis B in Tunisia].
    Houissa R; Gharbi Y; Coursaget P; el Goulli N
    Arch Inst Pasteur Tunis; 1988; 65(1-2):53-8. PubMed ID: 3178366
    [No Abstract]   [Full Text] [Related]  

  • 48. Trial of a micro-ELISA system for detecting hepatitis B surface antigen.
    Farr AD
    Med Lab Sci; 1979 Apr; 36(2):115-20. PubMed ID: 381824
    [No Abstract]   [Full Text] [Related]  

  • 49. [Decreasing the risk of hepatitis B transfer by regular screening examination of donors for glutamic-oxaloacetic transaminase and for hepatitis BS antigen].
    Novak J; Urbánková J
    Probl Gematol Pereliv Krovi; 1977 Jul; 22(7):56-7. PubMed ID: 882530
    [No Abstract]   [Full Text] [Related]  

  • 50. Detection of an acute asymptomatic HBsAg negative hepatitis B virus infection in a blood donor by HBV DNA testing.
    Weber B; Mühlbacher A; Melchior W
    J Clin Virol; 2005 Jan; 32(1):67-70. PubMed ID: 15572009
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Association between Class I HLA alleles and HBs antigen carrier status among blood donors in Senegal].
    Dieye A; Obami-Itou V; Barry MF; Raphenon G; Thiam A; Ndiaye R; Ndiaye M; Diaw ML; Diakhate L
    Dakar Med; 1999; 44(2):166-70. PubMed ID: 11957279
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of a new automated assay for hepatitis B surface antigen (HBsAg) detection VIDAS HBsAg Ultra.
    Weber B; Van der Taelem-Brulé N; Berger A; Simon F; Geudin M; Ritter J
    J Virol Methods; 2006 Jul; 135(1):109-17. PubMed ID: 16567005
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Evaluation of two methods for detecting HBS antigen in serum (author's transl)].
    Martine J; Hasselot N; Berthet M
    Med Trop (Mars); 1979; 39(6):657-8. PubMed ID: 393938
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of HbsAg and HBV DNA in serum and saliva of HBV carriers.
    Noppornpanth S; Sathirapongsasuti N; Chongsrisawat V; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2000 Jun; 31(2):419-21. PubMed ID: 11127351
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests.
    Schmidt M; Nübling CM; Scheiblauer H; Chudy M; Walch LA; Seifried E; Roth WK; Hourfar MK
    Vox Sang; 2006 Oct; 91(3):237-43. PubMed ID: 16958836
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The emerging pattern of post-transfusion hepatitis.
    Alter HJ; Holland PV; Purcell RH
    Am J Med Sci; 1975; 270(2):329-34. PubMed ID: 1235474
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-specific and false-negative reactions in detection of HBsAg.
    Stancek D; Blaskovicová H; Holenová Z; Husár K
    Acta Virol; 1982 May; 26(3):169-73. PubMed ID: 6127017
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of preventive applications on prevalence of hepatitis B virus and hepatitis C virus infections in West Turkey.
    Sakarya S; Oncu S; Ozturk B; Oncu S
    Saudi Med J; 2004 Aug; 25(8):1070-2. PubMed ID: 15322600
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Distribution of hepatitis B surface antigen subtypes in the serum of hepatitis patients and healthy blood donors].
    Pohl O; Novák E; Zgyerka S; Hollós I
    Orv Hetil; 1980 Jul; 121(30):1811-7. PubMed ID: 7454292
    [No Abstract]   [Full Text] [Related]  

  • 60. [Prevention of post-transfusion hepatitis. I. Evaluation of the effectiveness of donor selection by the test for HBsAg].
    Bondarenko MP; Stepanov GP
    Zh Mikrobiol Epidemiol Immunobiol; 1981 May; (5):44-8. PubMed ID: 7269917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.